Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
DAWN
DAWN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
DAWN News
Monteverde Law Firm Investigates Multiple Biopharmaceutical Companies
6h ago
Globenewswire
Wall Street Analysts Adjust Ratings
8h ago
Benzinga
Investor Rights Law Firm Investigates Transactions
1d ago
PRnewswire
Day One Biopharmaceuticals Soars 100% on $2.5 Billion Acquisition
2d ago
Yahoo Finance
Day One Biopharmaceuticals to Merge with Servier for $2.5 Billion
3d ago
Yahoo Finance
U.S. Stocks Decline on Weak Jobs Report
3d ago
Fool
U.S. Stocks Decline Amid Weak Jobs Report
3d ago
NASDAQ.COM
Ademi LLP Investigates Day One for Possible Legal Violations
4d ago
PRnewswire
U.S. Stocks Decline Amid Weak Retail Sales Data
4d ago
Benzinga
Bank Stocks Decline While Fertilizer Stocks Rally Amid Supply Concerns
4d ago
CNBC
Day One Biopharmaceuticals Acquired for $2.5 Billion, Leading to Surge in Stock Prices.
4d ago
Barron's
Marvell Technology Surges After Strong Q4 Earnings Report
4d ago
Benzinga
Servier to Acquire Day One Biopharmaceuticals for $21.50 per Share
4d ago
Benzinga
Servier Acquires Day One Biopharmaceuticals for $2.5 Billion
4d ago
PRnewswire
Servier Acquires Day One Biopharmaceuticals for $2.5 Billion
4d ago
PRnewswire
Servier Acquires Day One Biopharmaceuticals for $2.5 Billion
4d ago
Newsfilter
Show More News
